Penumbra
PEN
#1748
Rank
$9.30 B
Marketcap
$242.54
Share price
-0.40%
Change (1 day)
-6.20%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Penumbra (PEN) - Total debt

Total debt on the balance sheet as of September 2024 : $0.22 Billion USD

According to Penumbra's latest financial reports the company's total debt is $0.22 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Penumbra - Total debt on balance sheet (from 2018 to 2024)

Total debt by year

Year Total debt Change
2023-12-31$0.23 B-0.61%
2022-12-31$0.23 B35.85%
2021-12-31$0.17 B124.58%
2020-12-31$77.27 M-6.1%
2019-12-31$82.29 M
2018-12-31N/A
2013-12-31$6 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
$32.72 M-85.56%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.81 B 261.35%๐Ÿ‡บ๐Ÿ‡ธ USA